Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects

Netherlands Journal of Medicine

Volumn 63, Issue 2, 2005, Pages 64-69

  Ezenwaka, C E ^a   Kalloo, R ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CENTRAL AMERICA; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIET RESTRICTION; DIETARY INTAKE; ETHNOLOGY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CARIBBEAN REGION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 14844288288     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Republic of Trinidad and Tobago. Office of the Prime Minister. Central Statistical Office. Population and Housing Census. Vol. 11: Age Structure, Religion, Ethnic Group, Education. Port of Spain: Central Statistical Office, 1998.
2. Miller GJ, Beckles GLA, Maude GH, et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol 1989;18:808-17.
3. Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and noninsulin dependent diabetes mellitus and associated risk Factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Comm Health 1996;50:497-504.
4. Ezenwaka EC, Davis G. Increased cardiovascular risk factors in newly diagnosed type 2 diabetic patients in a primary health care centre in Trinidad. Diabetes Res Clin Pract 2000;50(2):137-45.
5. Ezenwaka EC, Offiah NV. Cardiovascular risk of obese and non-obese patients with Type 2 diabetes in West Indies. J Biomed Sc 2001;8(4):314-20.
6. Ezenwaka EC, Offiah NV. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clin Exp Med 2001;1(2):91-8.
7. Ezenwaka CE, Kalloo R. Glycaemic responses after ingestion of 3 local carbohydrate-based foods in West Indian patients with type-2 diabetes mellitus. Clin Nutr 2004;23(4):631-40.
8. Ezenwaka CE, Kalloo R. The postprandial glucose levels in type 2 diabetic patients visiting 2 different primary care clinics in a developing country. West Indian Med J. In press.
9. Pan W-h, Chiang BN. Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan - a unique experience. Atherosclerosis 1995;118:285-95.
10. Posadas-Romero C, Tapia-Conyer R, Lerman-Garber I, et al. Cholesterol levels and prevalence of hypercholesterolaemia in a Mexican adult population. Atherosclerosis 1995;118:275-84.
11. El Mugamer IT, Ali Zayat AS, Hossain MM, Pugh RNH. Diabetes, obesity and hypertension in urban and rural people of Bedoum origin in the United Arab Emirates. J Trop Med Hyg 1995;98:407-15.
12. Anmed AF, Abdelsalam SA, Mahmoud ME, Gadri MA, A case control study of the incidence of coronary heart disease risk factors in Saudis at Almadina Almounawarah. Saudi Med J 1993;14:46-51.
13. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003;26(7):2015-20.
14. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-8.
15. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyper-insulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
16. Zietz B, Herfarth H, Paul G, et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 2003;545(2-3):103-4.
17. Pellme F, Smith U, Funahashi T, et al. Circulating adiponectin levels are reduced in non-obese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003;52(5):1182-6.
18. Valsamakis G, Chetty R, McTeman PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 2003;25(2):131-5.
19. Ezenwaka CE, Kalloo R, Uhlig M, Eckel J. Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus. Horm Metab Res 2004;36(4):238-42.
20. The DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association Diagnostic criteria. Lancet 1999;354:617-21.
21. Friedwald WT, Levy RI. Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
23. Hotta K, Funahashi T, Arita Y, et al. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9.
24. Yu JG, Javorschi S, Hevener AL, et al. The effect of thiazolidinedione on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002;51:2968-74.
25. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:717-20.
26. Ezenwaka CE, Offiah NV. Abdominal obesity in type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies. Scand J Prim Health Care 2002;20:177-82.
27. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma Adiponectin concentrations in children: relationships with obesity and insulinaemia. J Clin Endocrin Metab 2002;87:4652-6.
28. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004;89(6):2563-8.
29. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148(3):293-300.
30. Ouchi N, Kilhara S, Arita Y, et al. Adiponectin, adipocyte-derived plasma protein, inhibits endothelial N F-kB signalling through camp-dependent pathway. Circulation 2000;102:1296-301.
31. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6.
32. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, et al. Lower serum adiponectin levels in African-American boys. Obes Res 2003;11(11):1384-90.
33. Hanley AJ, Connelly PW, Harris SB, et al. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care 2003;26(12):3219-25.
34. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipocyte specific protein, adiponectin in obesity. Biochem Biophys Res Commun 1999;257:79-83.